Results 31 to 40 of about 242,918 (218)

The changing role of radiation therapy in the management of oligometastatic disease

Technical Innovations & Patient Support in Radiation Oncology, 2017
It is clear from surgical series that there are selected patients presenting with localised metastatic disease who can be cured by radical ablation of the metastasis.
H. Tharmalingham, P.J. Hoskin
doaj   +1 more source

Stereotactic Arrhythmia Radioablation as a Novel Treatment Approach for Cardiac Arrhythmias: Facts and Limitations

Biomedicines, 2021
Stereotactic ablative radiotherapy (SABR) is highly focused radiation therapy that targets well-demarcated, limited-volume malignant or benign tumors with high accuracy and precision using image guidance.
Marina Chalkia, Vassilis Kouloulias, Dimitris Tousoulis, Spyridon Deftereos, Dimitris Tsiachris, Dimitrios Vrachatis, Kalliopi Platoni   +6 more
doaj   +1 more source

The role of stereotactic radiotherapy in the treatment of the local recurrence of colorectal cancer: A case report [PDF]

Archive of Oncology
Colorectal cancer is one of the most common malignant diseases worldwide. A multidisciplinary approach to treatment involves surgery and chemotherapy, while radiotherapy is used in the treatment of tumors localized in the pelvis.
Radosavljević Kristina, Ivanov Olivera, Bojović Marko, Ličina Jelena, Protić Mlađan, Prvulović-Bunović Nataša   +5 more
doaj   +1 more source

Stereotactic Ablative Radiotherapy for Pulmonary Oligometastases and Oligometastatic Lung Cancer [PDF]

, 2014
An increasing body of experience suggests that oligometastasis represents a minimal metastatic state with the potential for cure or prolonged survival in selected patients treated with radical local therapy to all identified sites of disease.
Mornex, Francoise, Loo, Billy W., Thariat, Juliette, Ricardi, Umberto, Shultz, David Benjamin, Filippi, Andrea Riccardo   +5 more
core   +1 more source

SABR in oligometastatic breast cancer: Current status and future directions

Breast, 2021
Oligometastatic breast cancer (OMBC) is a heterogeneous disease with intrinsic biological diversity. It is increasingly accepted in clinical practice that patients with OMBC could be treated with the expectation of long-term disease remission.
Rachel Stewart, Michelle White, Jennifer Tan, Shankar Siva, Lama Karroum, Steven David   +5 more
doaj   +1 more source

Stereotactic ablative radiotherapy and immunotherapy combinations: turning the future into systemic therapy? [PDF]

The British Journal of Radiology, 2016
Radiotherapy (RT) is effective at cytoreducing tumours and until relatively recently the focus in radiobiology has been on the direct effects of RT on the tumour. Increasingly, however, the effect of RT on the tumour vasculature, tumour stroma and immune system are recognized as important to the overall outcome.
Walshaw, Richard C, Honeychurch, Jamie, Illidge, Timothy M; id_orcid 0000-0003-3191-7324   +2 more
openaire   +3 more sources

Stereotactic ablative radiotherapy in patients with refractory ventricular tachyarrhythmia

European Heart Journal Supplements, 2022
Abstract Stereotactic ablative body radiotherapy (SABR) is an innovative therapeutic approach in patients (pts) with a diagnosis of refractory ventricular tachyarrhythmia (VT) after the use of drugs, radiofrequency catheter ablation, and/or defibrillator (ICD) implant. The current efficacy data of SABR are limited and several prospective
Molon, Giulio, Giaj-Levra, Niccolò, Costa, Alessandro, Bonapace, Stefano, Cuccia, Francesco, Marinelli, Alessio, Trachanas, Konstantinos, Sicignano, Gianluisa, Alongi, Filippo   +8 more
openaire   +3 more sources

Single-Fraction Stereotactic Ablative Body Radiotherapy to the Lung - The Knockout Punch

, 2022
This overview summarises the current evidence on efficacy and safety of single-fraction stereotactic ablative body radiotherapy (SABR) for primary lung cancers and lung metastases, in comparison with the more widely adapted multi-fraction SABR regimens ...
Guckenberger, M., Harden, S., Alongi, F, Plumridge, N, Slotman, B J, Guckenberger, Matthias; https://orcid.org/, Singh, A. K., Siva, S., Singh, A K, Stephans, K, Tjong, M. C., Plumridge, N., Louie, A V, Harden, S, Videtic, G, Tjong, M C, Slotman, B. J., Videtic, G., Stephans, K., Siva, Shankar; https://orcid.org/, Alongi, F., Louie, A. V.   +21 more
core   +2 more sources

Successful Noninvasive 12-Lead ECG Mapping-Guided Radiotherapy of Inaccessible Ventricular Tachycardia Substrate Due to Mechanical Valves

JACC: Case Reports, 2023
In patients presenting with refractory ventricular tachycardia (VT) and aortic and mitral mechanical prosthetic valves, traditional catheter ablation is challenging.
Lucas K. Keyt, MD, Todd Atwood, PhD, DABR, Andrew Bruggeman, MD, Arno J. Mundt, MD, Gregory K. Feld, MD, David E. Krummen, MD, Gordon Ho, MD   +6 more
doaj   +1 more source

Commissioning and initial stereotactic ablative radiotherapy experience with Vero [PDF]

Journal of Applied Clinical Medical Physics, 2014
The purpose of this study is to describe the comprehensive commissioning process and initial clinical performance of the Vero linear accelerator, a new radiotherapy device recently installed at UT Southwestern Medical Center specifically developed for delivery of image‐guided stereotactic ablative radiotherapy (SABR).
Solberg, Timothy D., Medin, Paul M., Ramirez, Ezequiel, Ding, Chuxiong, Foster, Ryan D., Yordy, John   +5 more
openaire   +2 more sources